Trial · NCT03907488
Adverse events402
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 402
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Arm I (Chemotherapy, Nivolumab, Radiation) | 251 | 481 | |
| other | Anemia | Blood and lymphatic system disorders | Arm II (Chemotherapy, Brentuximab Vedotin, Radiation) | 252 | 476 | |
| other | Eosinophilia | Blood and lymphatic system disorders | Arm I (Chemotherapy, Nivolumab, Radiation) | 23 | 481 | |
| other | Eosinophilia | Blood and lymphatic system disorders | Arm II (Chemotherapy, Brentuximab Vedotin, Radiation) | 28 | 476 | |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm I (Chemotherapy, Nivolumab, Radiation) | 8 | 481 | |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm II (Chemotherapy, Brentuximab Vedotin, Radiation) | 30 | 476 | |
| other | Sinus tachycardia | Cardiac disorders | Arm I (Chemotherapy, Nivolumab, Radiation) | 46 | 481 | |
| other | Sinus tachycardia | Cardiac disorders | Arm II (Chemotherapy, Brentuximab Vedotin, Radiation) | 71 | 476 | |
| other | Hypothyroidism | Endocrine disorders | Arm I (Chemotherapy, Nivolumab, Radiation) | 38 | 481 | |
| other | Hypothyroidism | Endocrine disorders | Arm II (Chemotherapy, Brentuximab Vedotin, Radiation) | 3 | 476 | |
| other | Blurred vision | Eye disorders | Arm I (Chemotherapy, Nivolumab, Radiation) | 28 | 481 | |
| other | Blurred vision | Eye disorders | Arm II (Chemotherapy, Brentuximab Vedotin, Radiation) | 24 | 476 | |
| other | Abdominal pain | Gastrointestinal disorders | Arm I (Chemotherapy, Nivolumab, Radiation) | 93 | 481 | |
| other | Abdominal pain | Gastrointestinal disorders | Arm II (Chemotherapy, Brentuximab Vedotin, Radiation) | 164 | 476 | |
| other | Bloating | Gastrointestinal disorders | Arm I (Chemotherapy, Nivolumab, Radiation) | 13 | 481 | |
| other | Bloating | Gastrointestinal disorders | Arm II (Chemotherapy, Brentuximab Vedotin, Radiation) | 27 | 476 | |
| other | Constipation | Gastrointestinal disorders | Arm I (Chemotherapy, Nivolumab, Radiation) | 238 | 481 | |
| other | Constipation | Gastrointestinal disorders | Arm II (Chemotherapy, Brentuximab Vedotin, Radiation) | 240 | 476 | |
| other | Diarrhea | Gastrointestinal disorders | Arm I (Chemotherapy, Nivolumab, Radiation) | 130 | 481 | |
| other | Diarrhea | Gastrointestinal disorders | Arm II (Chemotherapy, Brentuximab Vedotin, Radiation) | 173 | 476 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03907488/events